BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $214,000 | -36.5% | 3,964 | -24.5% | 0.14% | -36.0% |
| Q2 2022 | $337,000 | -19.6% | 5,252 | -2.9% | 0.22% | -9.4% |
| Q1 2022 | $419,000 | -12.9% | 5,407 | -3.5% | 0.24% | -9.9% |
| Q4 2021 | $481,000 | -23.9% | 5,602 | -28.7% | 0.27% | -32.5% |
| Q3 2021 | $632,000 | -2.0% | 7,853 | -2.1% | 0.40% | -3.1% |
| Q2 2021 | $645,000 | -14.1% | 8,018 | -14.4% | 0.42% | -23.4% |
| Q4 2020 | $751,000 | -1.6% | 9,363 | -1.5% | 0.54% | -10.1% |
| Q3 2020 | $763,000 | -6.2% | 9,503 | +0.6% | 0.60% | -11.7% |
| Q2 2020 | $813,000 | +13.4% | 9,443 | +7.0% | 0.68% | -6.7% |
| Q1 2020 | $717,000 | +1.0% | 8,825 | +3.9% | 0.73% | +26.8% |
| Q4 2019 | $710,000 | -3.1% | 8,490 | +1.4% | 0.58% | -9.5% |
| Q3 2019 | $733,000 | +9.9% | 8,375 | +2.9% | 0.64% | +12.3% |
| Q2 2019 | $667,000 | +10.6% | 8,138 | +9.8% | 0.57% | +8.4% |
| Q1 2019 | $603,000 | +17.1% | 7,413 | -5.3% | 0.52% | +2.5% |
| Q4 2018 | $515,000 | -14.2% | 7,828 | +0.6% | 0.51% | -1.5% |
| Q3 2018 | $600,000 | +32.5% | 7,783 | +26.8% | 0.52% | +21.8% |
| Q2 2018 | $453,000 | +38.5% | 6,138 | +22.2% | 0.43% | +36.0% |
| Q1 2018 | $327,000 | +8.3% | 5,024 | +7.6% | 0.31% | +18.9% |
| Q4 2017 | $302,000 | +31.9% | 4,669 | +28.1% | 0.26% | +25.1% |
| Q3 2017 | $229,000 | +7.5% | 3,644 | +3.6% | 0.21% | +5.5% |
| Q2 2017 | $213,000 | -22.0% | 3,519 | -10.1% | 0.20% | -35.5% |
| Q2 2015 | $273,000 | 0.0% | 3,915 | -1.9% | 0.31% | +9.5% |
| Q1 2015 | $273,000 | -6.5% | 3,990 | 0.0% | 0.28% | -5.7% |
| Q4 2014 | $292,000 | – | 3,990 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |